Literature DB >> 6308407

Planning proton therapy of the eye.

M Goitein, T Miller.   

Abstract

We describe a program for planning treatments of the eye with charged particle beams. Many of its features apply to treatment planning programs in general. These include the three-dimensional definition of the tumor volume and of normal structures, the possibility of delivering the treatment beam from any direction in space, the provision of arbitrary viewpoints including a "beam's eye" point of view, the design and fabrication of the field shaping aperture, the specification of the necessary beam quality (range and modulation), the calculation and display of isodose contours on any plane in space and on relevant surfaces, the identification of the extent to which normal structures are included or excluded from the beam, and the stimulation of the desired alignment film with which patient alignment can be verified.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308407     DOI: 10.1118/1.595258

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  25 in total

1.  Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.

Authors:  Aline I Riechardt; Bettina Karle; Dino Cordini; Jens Heufelder; Volker Budach; Antonia M Joussen; Johannes Gollrad
Journal:  Strahlenther Onkol       Date:  2017-06-19       Impact factor: 3.621

2.  Radiotherapy in ophthalmology : 2004 Jules Gonin lecture of the Retina Research Foundation.

Authors:  Leonidas Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07       Impact factor: 3.117

3.  Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy.

Authors:  Nicholas Koch; Wayne D Newhauser; Uwe Titt; Dan Gombos; Kevin Coombes; George Starkschall
Journal:  Phys Med Biol       Date:  2008-02-25       Impact factor: 3.609

4.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

Review 5.  Treatment planning with heavy ions.

Authors:  P Chauvel
Journal:  Radiat Environ Biophys       Date:  1995-03       Impact factor: 1.925

6.  Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.

Authors:  Aline I Riechardt; Julian P Klein; Dino Cordini; Jens Heufelder; Matus Rehak; Ira Seibel; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-20       Impact factor: 3.117

7.  Monte Carlo Simulation of the Treatment of Eye Tumors with (106)Ru Plaques: A Study on Maximum Tumor Height and Eccentric Placement.

Authors:  Lorenzo Brualla; Francisco J Zaragoza; Wolfgang Sauerwein
Journal:  Ocul Oncol Pathol       Date:  2014-05-07

8.  Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.

Authors:  Aline I Riechardt; Daniel Pilger; Dino Cordini; Ira Seibel; Enken Gundlach; Annette Hager; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-18       Impact factor: 3.117

9.  Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.

Authors:  Pietro Valerio Foti; Antonio Longo; Michele Reibaldi; Andrea Russo; Giuseppe Privitera; Corrado Spatola; Luigi Raffaele; Vincenzo Salamone; Renato Farina; Stefano Palmucci; Andrea Musumeci; Rosario Caltabiano; Marco Ragusa; Cesare Mariotti; Teresio Avitabile; Pietro Milone; Giovanni Carlo Ettorre
Journal:  Radiol Med       Date:  2016-10-17       Impact factor: 3.469

10.  Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Authors:  Alexander Böker; Daniel Pilger; Dino Cordini; Ira Seibel; Aline I Riechardt; Antonia M Joussen; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.